
Drugs giant GSK is axing up to around 350 research and development jobs across the US and UK as part of an ongoing overhaul of the division.
It is understood around 50 UK jobs so far are being cut in the group’s main UK R&D hub in Stevenage, Hertfordshire, although the final number of roles being impacted in Britain and the US are set to be confirmed in the coming months.